Counter CM - Search Results

1

Expression of transgenes enriched in rare codons is enhanced by the MAPK pathway.

Peterson J, Li S, Kaltenbrun E, Erdogan O, Counter CM. Peterson J, et al. Among authors: counter cm. Sci Rep. 2020 Dec 17;10(1):22166. doi: 10.1038/s41598-020-78453-5. Sci Rep. 2020. PMID: 33335127 Free PMC article.

2

Characterization of the repeat-tract instability and mutator phenotypes conferred by a Tn3 insertion in RFC1, the large subunit of the yeast clamp loader.

Xie Y, Counter C, Alani E. Xie Y, et al. Genetics. 1999 Feb;151(2):499-509. doi: 10.1093/genetics/151.2.499. Genetics. 1999. PMID: 9927446 Free PMC article.

3

Rare codons regulate KRas oncogenesis.

Lampson BL, Pershing NL, Prinz JA, Lacsina JR, Marzluff WF, Nicchitta CV, MacAlpine DM, Counter CM. Lampson BL, et al. Among authors: counter cm. Curr Biol. 2013 Jan 7;23(1):70-5. doi: 10.1016/j.cub.2012.11.031. Epub 2012 Dec 13. Curr Biol. 2013. PMID: 23246410 Free PMC article.

4

Rare codons capacitate Kras-driven de novo tumorigenesis.

Pershing NL, Lampson BL, Belsky JA, Kaltenbrun E, MacAlpine DM, Counter CM. Pershing NL, et al. Among authors: counter cm. J Clin Invest. 2015 Jan;125(1):222-33. doi: 10.1172/JCI77627. Epub 2014 Dec 1. J Clin Invest. 2015. PMID: 25437878 Free PMC article.

5

Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.

Ali M, Kaltenbrun E, Anderson GR, Stephens SJ, Arena S, Bardelli A, Counter CM, Wood KC. Ali M, et al. Among authors: counter cm. Nat Commun. 2017 Jun 8;8:15617. doi: 10.1038/ncomms15617. Nat Commun. 2017. PMID: 28593995 Free PMC article.

6

A model for RAS mutation patterns in cancers: finding the sweet spot.

Li S, Balmain A, Counter CM. Li S, et al. Among authors: counter cm. Nat Rev Cancer. 2018 Dec;18(12):767-777. doi: 10.1038/s41568-018-0076-6. Nat Rev Cancer. 2018. PMID: 30420765 Review.

7

Capturing the primordial Kras mutation initiating urethane carcinogenesis.

Li S, MacAlpine DM, Counter CM. Li S, et al. Among authors: counter cm. Nat Commun. 2020 Apr 14;11(1):1800. doi: 10.1038/s41467-020-15660-8. Nat Commun. 2020. PMID: 32286309 Free PMC article.

8

Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo.

Sawyer JK, Kabiri Z, Montague RA, Allen SR, Stewart R, Paramore SV, Cohen E, Zaribafzadeh H, Counter CM, Fox DT. Sawyer JK, et al. Among authors: counter cm. PLoS Genet. 2020 Dec 9;16(12):e1009228. doi: 10.1371/journal.pgen.1009228. eCollection 2020 Dec. PLoS Genet. 2020. PMID: 33296356 Free PMC article.

9

Signaling levels mold the RAS mutation tropism of urethane.

Li S, Counter CM. Li S, et al. Among authors: counter cm. Elife. 2021 May 17;10:e67172. doi: 10.7554/eLife.67172. Elife. 2021. PMID: 33998997 Free PMC article.

10

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment.

Klomp JE, Lee YS, Goodwin CM, Papke B, Klomp JA, Waters AM, Stalnecker CA, DeLiberty JM, Drizyte-Miller K, Yang R, Diehl JN, Yin HH, Pierobon M, Baldelli E, Ryan MB, Li S, Peterson J, Smith AR, Neal JT, McCormick AK, Kuo CJ, Counter CM, Petricoin EF 3rd, Cox AD, Bryant KL, Der CJ. Klomp JE, et al. Among authors: counter cm. Cell Rep. 2021 Nov 30;37(9):110060. doi: 10.1016/j.celrep.2021.110060. Cell Rep. 2021. PMID: 34852220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page